首页> 外文期刊>RSC Advances >Immune response effects of diverse vaccine antigen attachment ways based on the self-made nanoemulsion adjuvant in systemic MRSA infection
【24h】

Immune response effects of diverse vaccine antigen attachment ways based on the self-made nanoemulsion adjuvant in systemic MRSA infection

机译:基于自制纳米乳佐剂的多种疫苗抗原附着方式对全身MRSA感染的免疫应答作用

获取原文
           

摘要

Nanoemulsion adjuvants-based vaccines have potent induced immune responses against methicillin-resistant Staphylococcus aureus (MRSA) infection. However, the efficacies and immune responses of different antigen-attaching ways on self-made nanoemulsion adjuvants remain unknown. In this study, we designed three formulations of nanoemulsion adjuvants (encapsulation, mixture, and combination) to explore their immune response-enhancing effects and their underlying mechanism in a systemic infection model of MRSA. Our results showed that the three nanoemulsion-attachment ways formulated with a fusion antigen of MRSA (Hla _(H35L) IsdB _(348–465) ) all improved humoral and cellular immune responses. When compared with the mixture and combination formulations, the nanoemulsion-encapsulation group effectively promoted the antigen uptake of dendritic cells (DCs) in vitro , the activation of DC in draining lymph nodes and the delayed release of antigen at injection sites in vivo . Moreover, the encapsulation group induced a more ideal protective efficacy in a MRSA sepsis model by inducing more potent antibody responses and a Th1/Th17 biased CD4 ~(+) T cell response when compared with the other two attachment ways. Our findings suggested that the encapsulated formulation of vaccine with nanoemulsion adjuvant is an effective attachment way to provide protective immunity against MRSA infection.
机译:基于纳米乳液佐剂的疫苗对耐甲氧西林的金黄色葡萄球菌(MRSA)感染具有有效的诱导免疫反应。然而,不同的抗原附着方式对自制纳米乳液佐剂的功效和免疫应答仍然未知。在这项研究中,我们设计了三种纳米乳剂佐剂(封装,混合和组合),以探讨它们在MRSA系统感染模型中的免疫应答增强作用及其潜在机制。我们的结果表明,使用MRSA融合抗原(Hla _(H35L)IsdB _(348-465))配制的三种纳米乳剂附着方法均改善了体液和细胞免疫反应。当与混合物和组合制剂相比时,纳米乳液包封组在体外有效促进树突状细胞(DC)的抗原摄取,引流淋巴结中DC的活化以及体内注射部位抗原的延迟释放。此外,与其他两种附着方式相比,封装组通过诱导更有效的抗体反应和Th1 / Th17偏向的CD4〜(+)T细胞反应,在MRSA脓毒症模型中诱导了更理想的保护效果。我们的研究结果表明,纳米乳佐剂的疫苗包封制剂是一种有效的附着方式,可提供针对MRSA感染的保护性免疫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号